Jessica A. Zeaske

She previously served as Director of Healthcare Investments at GE Ventures and a Principal at Lemhi Ventures, a fund investing in health care services with a focus on market disruption. Prior to joining Lemhi, Jessica worked on forming, spinning out and investing in health companies at Greenspring Advisors and University of Minnesota.

Jessica currently serves on the Boards of Avalon Healthcare Solutions, Heartbeat Health, Ideon, and as a Board Observer at Abacus Insights and Eleanor Health. She has a breadth of company-formation to growth-stage experience across health tech-enabled services companies such as Bind On-Demand Health Insurance (acquired by UHC, rebranded as Surest), Medication Management Systems (acquired by Genoa), Arcadia.io, PlanSource, Genome Medical and Wildflower Health. Over the years, Jessica has Chaired multiple Audit and Compensation Committees as well as serve on Nomination and Financing Committees.

Outside of Echo, Jessica serves on the Board of CareQuest Institute for Oral Health, a non-profit seeking to improve oral health for all, and has served as a Trustee for Boston Medical Center’s Exceptional Care Without Exception Trust, and an Advisory Board member for Boston Children’s Hospital. She is a member of the National Association of Corporate Directors.

Jessica received an undergraduate degree with honors from Stanford University, graduated from Johns Hopkins School of Public Health with a Master of Health Science and PhD, and completed her MBA with a focus on Healthcare Administration at Regis University.

Jessica is based out of Echo’s Boston office.